Skip to main content

Home/ Cancer/ Group items tagged peer-reviewed delicious

Rss Feed Group items tagged

Matti Narkia

Oncology Journals - Guide to Internet Resources for Cancer - 0 views

  •  
    Cancer Related Medical Journals
Matti Narkia

List of Cancer-related Medical Journals at Cancer Spectrum: Journals - 0 views

  •  
    A List of Cancer-related Medical Journals
Matti Narkia

Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, ... - 0 views

  •  
    Holick MF.
    Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.
    Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S-88S. Review.
    PMID: 15585788 [PubMed - indexed for MEDLINE]
Matti Narkia

The Vitamin D Epidemic and its Health Consequences -- Holick 135 (11): 2739S -- Journal... - 0 views

  •  
    Holick MF.
    The vitamin D epidemic and its health consequences.
    J Nutr. 2005 Nov;135(11):2739S-48S.
    PMID: 16251641 [PubMed - indexed for MEDLINE]
Matti Narkia

Prospective study of predictors of vitamin D status and cancer incidence and mortality ... - 0 views

  •  
    Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
    Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
    J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.
    PMID: 16595781 [PubMed - indexed fo
Matti Narkia

The Lancet Oncology - 0 views

  •  
    Medical Journal (cancer related)
Matti Narkia

Prospective study of predictors of vitamin D status and cancer incidence and mortality ... - 0 views

  •  
    Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
Matti Narkia

An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of o... - 0 views

  •  
    Grant WB, Garland CF, Gorham ED.
    An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day.
    Recent Results Cancer Res. 2007;174:225-34.
    PMID: 17302200 [PubMed - in process]
Matti Narkia

In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human p... - 0 views

  •  
    Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells.
    Eur J Cancer Prev. 2006 Aug;15(4):353-61.
    PMID: 16835506 [PubMed - indexed fo
Matti Narkia

Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in h... - 0 views

  •  
    Flaig TW, Su LJ, Harrison G, Agarwal R, Glode LM.
    Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
    Int J Cancer. 2007 Jan 17; [Epub ahead of print]
    PMID: 17230508 [PubMed - as supplied
Matti Narkia

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. -... - 0 views

  •  
    Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glode LM.
    A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
    Invest New Drugs. 2007 Apr;25(2):139-46. Epub 2006 Nov 1.
    PMID
Matti Narkia

Prostate cancer chemoprevention by silibinin: bench to bedside. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R.
    Prostate cancer chemoprevention by silibinin: bench to bedside.
    Mol Carcinog. 2006 Jun;45(6):436-42. Review.
    PMID: 16637061 [PubMed - indexed for MEDLINE]
Matti Narkia

Prostate cancer prevention by silibinin. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R.
    Prostate cancer prevention by silibinin.
    Curr Cancer Drug Targets. 2004 Feb;4(1):1-11. Review.
    PMID: 14965263 [PubMed - indexed for MEDLINE]
Matti Narkia

Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induc... - 0 views

  •  
    Bemis DL, Capodice JL, Anastasiadis AG, Katz AE, Buttyan R.
    Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression.
    Nutr Cancer. 2005;52(2):202-12.
    PMID:
Matti Narkia

Curative Brachytherapy for Recurrent/Residual Tongue Cancer - Entrez PubMed - 0 views

  •  
    Ayukawa F, Shibuya H, Yoshimura RI, Watanabe H, Miura M.
    Curative Brachytherapy for Recurrent/Residual Tongue Cancer.
    Strahlenther Onkol. 2007 Mar;183(3):133-137.
    PMID: 17340071 [PubMed - as supplied by publisher]
Matti Narkia

Chemokines and squamous cancer of the head and neck: targets for therapeutic interventi... - 0 views

  •  
    Yeudall WA, Miyazaki H.
    Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention?
    Expert Rev Anticancer Ther. 2007 Mar;7(3):351-60.
    PMID: 17338654 [PubMed - in process]
Matti Narkia

PLoS Medicine - A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor... - 0 views

  •  
    Li H, Stampfer MJ, Hollis JBW, Mucci LA, Gaziano JM, et al. (2007)
    A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer.
    PLoS Med 4(3): e103
    doi:10.1371/journal.pmed.0040103
Matti Narkia

Mediterranean diet, micronutrients and prostate carcinoma: a rationale approach to prim... - 0 views

  •  
    Miano L.
    [Mediterranean diet, micronutrients and prostate carcinoma: a rationale approach to primary prevention of prostate cancer]
    Arch Ital Urol Androl. 2003 Sep;75(3):166-78. Review. Italian.
    PMID: 14661397 [PubMed - indexed for MEDLINE]
1 - 20 of 31 Next ›
Showing 20 items per page